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In a recent article for Critical Care, Bermejo-Martin and 
colleagues [1] describe Th   1 and Th  17  hypercytokinemia 
as an early signatur  e host response to severe infection by 
the pandemic variant of the inﬂ  uenza virus (nvH1N1). 
Th  e nvH1N1 infection is usually self-limiting in nature, 
but some patients develop severe symptoms requiring 
hospitalization [2]. Th   e host immune response may play 
an important role in poor outcomes after infection. Th  e 
human host immune response to nvH1N1 infection is 
unknown at this time and studies on its contribution to 
disease pathogenesis are desperately needed to improve 
prevention and treatment strategies.
By analyzing 29 cytokines and chemokines and the 
hemagglutination inhibition activity, Bermejo-Martin and 
colleagues [1] assessed the early host innate and adaptive 
immune responses in patients both mildly and severely 
infected with nvH1N1.     While infection with nvH1N1 
induces a typical innate response in both mild and severe 
cases, severe infections with respiratory involvement are 
characterized by an early secretion of Th  17 and Th  1 
cytokines. Th   us, hospitalized patients tend to show high 
systemic levels of mediators that stimulate Th  17 (IL-8, 
IL-9, IL-17, IL-6) and Th  1 responses (IFN-γ, TNF-α, 
IL-15, IL-12p70) [1]. Based on this ﬁ  nding, this study was 
able to highlight similarities between the cytokine 
response to severe H1N1 infection and the pathogenesis 
of asthma and some autoimmune diseases.
Th  e Th  1 response is primarily involved with host 
immune defense against intracellular pathogens by acti-
vating cellular immunity. Th  is response is eﬀ  ective  in 
eradicating infectious agents such as viruses [3]. Indeed, 
Th   1 cells produce IFN-γ and cytokines that are involved 
in monocyte/macrophage-mediated inﬂ  ammatory  res-
pon  ses [4]. When the Th  1 response is exhaustively 
prolonged, it may result in host damage. Moreover, other 
authors have reported that Th  1-dominated responses 
may be implicated in the pathogenesis of autoimmune 
disorders and chronic inﬂ  ammatory diseases [5]. Bermejo-
Martin and colleagues [1] found IL-15, IL-12p70, and IL-6 
to be particularly elevated following severe nvH1N1 
infection.    Th  ese three cytokines are known to mediate 
both antiviral and pro-inﬂ  ammatory  responses.  Th  e 
authors [1] also found a signiﬁ  cant inverse relationship of 
IL-6 and IL-8 with the pressure of oxygen in arterial 
blood in severely infected patients. Interestingly, previous 
studies had already reported high levels of speciﬁ  c 
proinﬂ   ammatory cytokines and chemokines in severe 
SARS coronavirus, H5N1 and respiratory syncytial virus 
infections [6-11].
Th   17 cells are required for host defense against intra-
cellular pathogens [12]. Th  17  promotes  inﬂ  ammation by 
inducing various pro-inﬂ   ammatory cytokines and 
chemo  kines, recruiting neutrophils, enhancing antibody 
production, and activating T cells [12]. Th   17 cells secrete 
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© 2010 BioMed Central LtdIL-17, IL-17F, and IL-22, thereby inducing a massive 
tissue reaction. Also, these cells secrete IL-21 to commu-
nicate with the cells of the immune system [13]. However, 
uncontrolled production of these cytokines induces 
tissue damage in infected tissues [12]. In addition, Th  17 
cells have a well-known role in clearing pathogens during 
infections and inducing tissue inﬂ   ammation in auto-
immune disease [13]. Interestingly, the key role of IL-17 
and its receptor in the immunopathology of inﬂ  uenza 
infection in a mouse model has just recently been 
reported [14].
Taken together, these ﬁ   ndings show that severe 
pandemic H1N1 infection is characterized by early 
elevation of key immune pro-inﬂ  ammatory  mediators 
participating in both Th  1  and  Th  17  inﬂ  ammatory 
responses. Th  is pro-inﬂ  ammatory response may be the 
cause of the severe respiratory symptoms caused by 
nvH1N1 infection. However, the authors also provide an 
alternative version of the story: Th   1 and Th  17  cytokines 
may reﬂ  ect a vigorous antiviral host response necessary 
for viral clearance. Th  is article [1] is the ﬁ  rst  that 
describes an association between severe inﬂ  uenza infec-
tion and a Th  17 response in humans. Th  e researchers 
correctly bring up the fact that a better understanding of 
the immune response to the new H1N1 virus could 
contribute to the design of more eﬀ  ective  therapies. 
Similarly, the results of this study reinforce the impor-
tance of early treatment with antivirals in those patients 
with high risk factors, such as pregnancy, asthma, and 
obesity, among others, to avoid triggering unwanted 
inﬂ   ammatory phenomena, which could explain the 
appearance of pneumonia in these patients. Th   e results of 
this work also support the study of drugs that modulate 
the immune response in the treatment of this disease 
[15]. Moreover, the study of genetic polymorphisms of 
relevant genes involved in the development of Th  1 and 
Th  17 immune responses in severely infected patients 
could be of interest, since these polymorphisms could 
strongly inﬂ  uence gene expression.
Further studies would help to understand the harmful 
or beneﬁ   cial roles that these cytokines play in the 
evolution of mild and severe nvH1N1 infection. But this 
report conﬁ   rms that Th  1 and Th  17 responses are 
distinctive hallmarks of severe respiratory compromise 
following nvH1N1 infection.
Abbreviations
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